eISSN: 2449-8580
ISSN: 1734-3402
Family Medicine & Primary Care Review
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
3/2020
vol. 22
 
Share:
Share:
Original paper

Biochemical parameters of patients with clinically silent cerebral lesions depend on gender – a preliminary study

Barbara Maciejewska
1
,
Anna Marcinkowska-Gapińska
2
,
Piotr Iwanowski
3
,
Zofia Maciejewska-Szaniec
4
,
Piotr Kowal
3

  1. Department of Phoniatrics and Audiology, Poznan University of Medical Sciences, Poland
  2. Department of Biophysics, P oznan University of Medical Sciences, Poland
  3. Department of Neurology, Poznan University of Medical Sciences, Poland
  4. Department of Oral Rehabilitation, Poznan University of Medical Sciences, Poland
Family Medicine & Primary Care Review 2020; 22(3): 208–211
Online publish date: 2020/10/16
Get citation
 
PlumX metrics:
 
1. Vermeer SE, Longastreth WT, Koudstaal PJ. Silent infarcts: a systematic review. Lancet Neurology 2007; 6(7): 611–619.
2. Vermeer SE, Heijer T, Koudstaal PJ, et al. Incidence and risk factors of silent brain infarcts in the population – based Rotterdam Scan Study. Stroke 2003; 34: 392–396.
3. Lowe G, Rumley A, Whincup PH, et al. Hemostatic and rheological variable and risk of cardiovascular disease. Semin Vasc Med 2002; 2(4): 429–439.
4. Yoshiyasu T, Kiyoto S, Masaya K, et al. Hemorheologic profile of plasma fibrynogen and blood viscosity from silent to acute and chronic cerebral infarctions. J Neurol Sci 1997; 147(1): 49–54.
5. Vermeer S, LongstrethW, Koudstaal P. Silent brain infarcts: a systematic review. Lancet Neurology 2007; 6(7): 611-619. To samo co 1
6. Chien S. What is clinical haemorheology? In: Gotoh F, Lechner H, eds. Clinical haemorheology: a new approach to cerebrovascular disease. Miasto: Royal Society of Medicine Services Limited; 1986: strony rozdziału od–do.
7. Quemada D. Blood rheology and its implication in flow of blood. In: Rodkiewicz CM, ed. Arteries and arterial blood flow. Vien–New York: Springer Verlag; 1983: 1-127. strony rozdziału od–do.
8. Lerche D, Bämler H, Kucera W, et al. Flow properties of blood and hemoreological methods of quantification. In: Scütt W, Klinkmann H, Lamprecht I, et al., eds. Physical characterization of biological cells. Basic research and clinic relevance. Berlin: Verlag Gesundheit GmbH; 1991: 189–214.
9. Chmiel H. Determination of blood rheological parameters and clinical application. Advances in Cardiovascular Physics 1979; 3: 1–44.
10. Schmid-Schönbein H, Rieger H, Fischer T. Blood fluidity as a consequence of red cell fluidity: flow properties of blood and flow behavior of blood in vascular diseases. Angiology 1980; 31: 301–319.
11. Dintenfass L. Blood as a near “ideal” emulsion: a retrospective on the concept of the red cell as a fluid drop, its implications for the structure of the red cell membrane. Biorheology 1990; 27: 149–161.
12. Baskurt OK, Hardeman MR, Rampling MW, et al. Handbook of hemorheology and hemodynamics. Amsterdam, Berlin, Oxford, Tokyo, Washington (DC): IOS Press; 2007.
13. Woo E, Chan YW, Yu YL, et al. Admission glucose level in relation to mortality and morbidity outcome in 252 stroke patients. Stroke 1988; 19: 185–191.
14. Kochanek PM, Hallenbeck JM. Polymorphonuclear leucocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke 1992; 23: 1367–1379
15. Chamorro A, Vila N, Ascaso C, et al. Early prediction of stroke severity. Role of erythrocyte sedimentation rate. Stroke 1995; 26: 573–576.
16. Liu Y, Dong Y-H, Lyu P-Y, et al. Hipertension-induced cerebral small vessel disease leading to cognitive impairment. Chin Med J (Engl) 2018; 131(5): 615–619.
17. Molisz A, Gutknecht P, Trzeciak B, et al. Ischemic stroke in general practice – risk factors, prognosis – prospective single center study. Fam Med Prim Care Rev 2016; 18(3): 298–301.
18. Marcinkowska-Gapińska A, Kowal P. Hemorheological studies of chosen clinical cases. J Med Sci 2015; 84(3): 197–200.
19. Czlonkowska A, Ryglewicz D, Lechowicz W. Basic analytical parameters as the predictive factors for 30 day case fatality rate in stroke. Acta Neurol Scand 1997; 95: 121–124.
20. Bhatia RS, Garg RK, Gaur S, et al. Predictive value of routine hematological and biochemical parameters on 30-day fatality in acute stroke. Neurol India 2004; 52(2): 220–223.
21. Wasilewski J, Poloński L. Importance of fibrinogen and the rheological properties of blood in atherosclerosis and coronary artery disease. Chor Serca Naczyń 2010; 7(2): 62–71.
22. Pulsinelli WA, Levy DE, Sigsbee B, et al. Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus. Am J Med 1983; 74: 540–544.
23. Woo J, Lau E, Kay R, et al. A case control study of some hematological and biochemical variables in acute stroke and their prognostic value. Neuroepidemiology 1990; 9: 315–320.
24. Beamer N, Coull BM, Sexton G, et al. Fibrinogen and the albumin-globulin ratio in recurrent stroke. Stroke 1993; 24: 1133–1139.
25. Adams HP, Olinger C, Biller J, et al. Usefulness of admission blood glucose in predicting outcome of acute cerebral infarction. Stroke 1987; 18: 296.
26. Bokura H, Yamaguchi S, Iijima K, et al. Metabolic syndrome is associated with silent ischemic brain lesions. Stroke 2008; 39: 1607–1609.
Copyright: © 2020 Family Medicine & Primary Care Review. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
 
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.